Filing excerpt
In August 2024, we launched Stelo, our biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin, as the first over-the-counter glucose biosensor in the U.S.
Source: Autobound Signal API · 82 signals tracked for Dexcom · updated
Get Dexcom's live signals in Claude or ChatGPT, or by API
What changed at Dexcom this week? Use Autobound signals for dexcom.com.Dexcom entered the consumer health market with the launch of Stelo, an OTC glucose sensor for non-insulin users. This strategic shift into a new channel requires building new capabilities in direct-to-consumer marketing, e-commerce, and retail distribution.
Filing excerpt
In August 2024, we launched Stelo, our biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin, as the first over-the-counter glucose biosensor in the U.S.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10kchannelShiftGet every 10-K signal for Dexcom and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Dexcom this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/382b59ec-a7f7-4ef7-a42f-c492c382c5b9 returns this record as JSON. POST /v1/companies/enrich returns every signal for dexcom.com.
{
"signal_id": "382b59ec-a7f7-4ef7-a42f-c492c382c5b9",
"signal_type": "sec-10k",
"signal_subtype": "channelShift",
"detected_at": "2026-02-17T06:33:02.596+00:00",
"company": {
"name": "Dexcom",
"domain": "dexcom.com"
},
"data": {
"detail": "Dexcom entered the consumer health market with the launch of Stelo, an OTC glucose sensor for non-insulin users. This strategic shift into a new channel requires building new capabilities in direct-to-consumer marketing, e-commerce, and retail distribution.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Launched Stelo, its first over-the-counter (OTC) biosensor, in August 2024",
"excerpts": "In August 2024, we launched Stelo, our biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin, as the first over-the-counter glucose biosensor in the U.S.",
"relevance": 0.9,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/dxcm-20251231.htm",
"filing_date": "2026-02-12",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "New channel tools needed",
"signal_category": "market",
"regions_mentioned": [
"U.S."
]
}
}
curl https://signals.autobound.ai/v1/signals/382b59ec-a7f7-4ef7-a42f-c492c382c5b9 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"dexcom.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.